Baer Law Blog - Latest Updates
FDA and NABP Partnership: Information-Sharing for Drug Compounding
The Food and Drug Administration (FDA) recently announced that it awarded a cooperative grant to the National…
FDA and FTC Issue Joint Warning to Pharmacy Selling Unapproved Products containing CBD
Earlier this month, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued a…
California Board of Pharmacy Investigates Jurisprudence Exam Cheating Scandal
The California State Board of Pharmacy (Board) administers the California Practice Standards and Jurisprudence Exam (CPJE), or…
California Expands Access to HIV Prevention Drugs
California Senate Bill 159, signed by Governor Gavin Newsom earlier this week, allows pharmacies to offer pre-exposure…
Dispensing an Emergency Supply of a Chronic Maintenance Drug Without a Prescription
Earlier this year, Colorado Governor Jared Polis signed House Bill 19-1077 Concerning Authorization for a Pharmacist to…
FTC Continues to Issue CBD Warning Letters
Earlier this week the Federal Trade Commission (FTC) sent out warning letters to three unnamed companies that…
New Colorado Law Allows Doctors to Recommend Medical Marijuana for Disabling Medical Conditions
Colorado lawmakers passed Senate Bill 19-013 (Concerning the Conditions for Medical Marijuana Use For Disabling Conditions, and, in…
FDA Issues Warning Letter to Curaleaf Over Its CBD Products
Last week, the Food and Drug Administration (FDA) sent a regulatory ‘Warning Letter‘ to Curaleaf, Inc. (Curaleaf)…
American Society for Pharmacy Law
Baer Law Firm is a proud legal sponsor of the 2019 American Society for Pharmacy Law Developments…
Electronic Prescribing of Controlled Substances in Colorado
Earlier this year, Colorado Governor Polis signed SB 19-079 Concerning a Requirement that Certain Practitioners Prescribe Controlled…